Find a Research Study

Displaying 1 - 8 of 8

CAPE

To evaluate long-term safety of Humira in pediatric patients (between the ages of 6 and 17 years inclusive at the time of enrollment) with moderately to severely active CD who are prescribed and treated in accordance with the approved local Humira product label under the conditions of routine clinical setting.

ImproveCareNow (ICN)

To improve patient care and achieve the best health outcomes possible for children with IBD.

SuperHEROES

To find out the effects of a chemical in Stevia on the symptoms of NAFLD.